The long noncoding RNA sONE represses triple‐negative breast cancer aggressiveness through inducing the expression of miR‐34a, miR‐15a, miR‐16, and let‐7a-Reference-Cited by-同舟云学术

The long noncoding RNA sONE represses triple‐negative breast cancer aggressiveness through inducing the expression of miR‐34a, miR‐15a, miR‐16, and let‐7a

Published:2019-04-09 Issue:11 Volume:234 Page:20286-20297
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Youness Rana A.¹^ORCID,Hafez Hafez M.²,Khallaf Emad²,Assal Reem A.³,Abdel Motaal Amira⁴⁵,Gad Mohamed Z.⁶

Affiliation:

1. Department of Pharmaceutical Biology, Faculty of Pharmacy and Biotechnology German University in Cairo New Cairo City Cairo Egypt

2. Department of General Surgery, Faculty of Medicine Cairo University, Kasr Al‐Ainy Cairo Egypt

3. Department of Pharmacology and Toxicology, Faculty of Pharmacy and Biotechnology German University in Cairo New Cairo City Cairo Egypt

4. Department of Pharmacognosy, College of Pharmacy King Khalid University Abha Saudi Arabia

5. Department of Pharmacognosy, Faculty of Pharmacy Cairo University Cairo Egypt

6. Department of Biochemistry, Faculty of Pharmacy and Biotechnology German University in Cairo New Cairo City Cairo Egypt

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.28629

Reference53 articles.

1. Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis

2. Breast cancer in young women: an overview

3. Expression Analysis of MALAT1, GAS5, SRA, and NEAT1 lncRNAs in Breast Cancer Tissues from Young Women and Women over 45 Years of Age

4. Developing therapeutic microRNAs for cancer

5. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma;Translational Oncology;2024-07

2. Puzzling out the role of MIAT LncRNA in hepatocellular carcinoma;Non-coding RNA Research;2024-06

3. MIAT LncRNA: A multifunctional key player in non-oncological pathological conditions;Non-coding RNA Research;2024-06

4. Identification of shared gene signatures in major depressive disorder and triple-negative breast cancer;BMC Psychiatry;2024-05-16

5. Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies;Pathology - Research and Practice;2024-04